Meet with us at ESMO Congress!
Premier Research will be at ESMO 2026, bringing together oncology, medical affairs, program strategy, and clinical delivery leaders to connect with the global oncology community and discuss the evolving demands of cancer drug development.
Across early- and late-phase development, our oncology and hematology teams combine therapeutic expertise with integrated clinical development capabilities to help navigate complex study designs, global execution, site and patient considerations, and medical oversight. Connect with our team in Madrid to discuss your program priorities and opportunities to move development forward with greater confidence.
Featured Presentations
Premier experts will also share research exploring important considerations for oncology trial design and execution:
- Quality Medical Oversight: Impact on Timeline Efficiency in Early-Phase Oncology Trials
- ePoster #: 4895eP
- Authors: Salini Naidu; Radhika (Sandy) Shah; Anna Osipoff
- Eligibility Criteria in Oncology Trials: Restrictiveness, Clarity, and Implications for Trial Conduct
- ePoster #: 4891eP
- Authors: Anna Osipoff; Radhika (Sandy) Shah; Salini Naidu
On-Site
- Siân Ratcliffe Smethurst, Chief Operating Officer
- Gwyn Bebb, Senior Vice President, Global Head of Medical Affairs & Medical Oncology Strategy
- Ashley Herrick, Vice President, Head of Immuno-Oncology
- Sandy Shah, Vice President, Medical Affairs
- Laure Hugret, Senior Director, Program Delivery
- Jordan Curry, Senior Director, Program Strategy
- Anna Osipoff, Medical Director
- Erin Finot – Senior Vice President, Oncology
- Ming Pei – Executive Director, Business Development
- Maria Igarreta – Senior Director, Business Development
- Veronica Yildirim – Director Business Development
- Loris Lopalco – Executive Director, Business Development
Fill out the form above to schedule a meeting with our on-site team.
Meet with our team at ESMO to discuss your oncology development strategy, clinical trial needs, and program priorities.
